Christopher Gibson - 08 Dec 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Footnote F1

The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Footnote F2

This transaction, representing a sale to cover the exercise price and related tax withholdings for 28,646 option shares, was executed in multiple trades at prices ranging from $20.014 to $20.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Footnote F3

Represents the conversion of Class B Common Stock into Class A Common Stock.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $20.00 to $20.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Footnote F6

The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Footnote F7

This option, originally reported in the Reporting Person's Form 3 as exercisable for Class B Common Stock, is in fact exercisable for Class A Common Stock. Upon exercise of the option, the Reporting Person has the right to require the Issuer to exchange any such shares of Class A Common Stock for a number of Class B Common Stock of equivalent value.

Footnote F8

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Footnote F9

Shares of Class B Common Stock held directly and indirectly by the Reporting Person were previously reported in Table I of Forms 4 filed by the Reporting Person. Commencing with this Form 4, shares of Class B Common Stock held directly and indirectly by the Reporting Person are to be reported in Table II of Form 4.

Footnote F10

The shares are held by LAHWRAN-3 LLC, of which the Reporting Person a member and a manager.

Footnote F11

The shares are held by LAHWRAN-4 LLC, of which the Reporting Person a member and a manager.

Footnote F12

The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.